A new study reveals that age-related hearing loss and Alzheimer's disease show distinct but converging patterns of growth globally, with projections suggesting both conditions will intensify by 2040.

As populations age worldwide, two conditions have become increasingly linked: age-related hearing loss and cognitive decline. Individually, each poses significant public health challenges. Together, they represent a growing intersection of disability that remains poorly understood globally.

A new analysis from the Global Burden of Disease (GBD) study offers the first large-scale examination of how these two conditions distribute across the globe and how their combined weight on aging populations is expected to shift through 2040.

Background: Why the Researchers Looked at This

The relationship between hearing loss and cognitive decline has emerged as significant research territory. Some studies suggest untreated hearing loss may accelerate cognitive aging. What has been missing is a comprehensive global picture of how these two conditions co-occur and how their combined burden is changing.

The GBD study offers a standardized framework for measuring disease burden across countries. By examining 30 years of data on both age-related hearing loss (ARHL) and Alzheimer's disease (AD) simultaneously, Liu and colleagues created a unified view of how these conditions affect older populations globally.

Disability-adjusted life-years (DALYs) measures the overall burden. Analyzing prevalence, incidence, mortality, and DALYs offers insight into whether a condition is becoming more common, who it affects most, and where health systems face greatest burden.

How the Study Was Done

The researchers assembled epidemiological data from 1990 to 2021 for both ARHL and AD across every country tracked by the GBD consortium. They used statistical models to project trends to 2040, examining patterns by age and sex to see whether women and men experience these conditions differently.

They measured the Socio-demographic Index (SDI), which captures a country's development level using income, education, and fertility. The team investigated whether wealthier nations experience these conditions at higher or lower rates. Frontier analysis identified which countries performed above or below expectations given their development level.

Finally, they examined the co-distribution of hearing loss and Alzheimer's by looking at country-level correlations to reveal whether regions with high rates of one condition also had high rates of the other.

What the Researchers Found

Age-related hearing loss showed relatively stable global prevalence between 1990 and 2021. In contrast, Alzheimer's disease incidence and DALYs increased steadily. While hearing loss burden remained stable, cognitive decline worsened, especially among women and those aged 75 and older. By 2040, both conditions are expected to grow, with Alzheimer's rising more sharply.

The relationship between economic development and disease burden followed a non-linear pattern. Countries with higher SDI values reported greater incidence of both conditions compared to lower-income nations. However, wealthier countries do not necessarily achieve proportionally lower disease burden simply by spending more. Wide performance gaps emerged, suggesting reporting quality, diagnostic infrastructure, and aging demographics play substantial roles.

At the country level, researchers found a positive association between ARHL and AD. Regions with higer hearing loss prevalence also had higher disability burdens from Alzheimer's disease. This likely reflects shared drivers: aging population structures, life expectancy gains in developed regions, and improved diagnostic infrastructure. The two do not necessarily cause each other; rather, they rise together where populations are aging rapidly.

What It Means for People with Hearing Loss

For adults with age-related hearing loss, this study underscores two important points. First, hearing loss remains a steady challenge across the globe. Second, the co-occurrence of hearing loss with cognitive conditions is not random: both rise together in aging populations, suggesting shared underlying biology.

Addressing hearing loss should be part of broader cognitive and sensory health planning for aging. Some research suggests treating hearing loss may slow cognitive decline. Untreated hearing loss compounds the challenge. Older adults who cannot hear well also face barriers to social engagement, a known risk factor for cognitive decline.

Public health systems need to prepare. Regions undergoing rapid demographic transition will face acute pressure. This is especially true in Asia and parts of Africa, where populations are aging but health infrastructure for sensory and cognitive care may be underdeveloped. Integrated care models addressing both hearing and cognitive health together represent a strategic opportunity.

Why Improving Access to Hearing Care Matters

The study's finding that ARHL and Alzheimer's burden rise together in aging populations highlights a critical gap: access to hearing care is uneven globally. In many lower-income and middle-income countries, hearing aids remain expensive, difficult to obtain, and often unavailable. This compounds disadvantage for older adults already facing cognitive and sensory challenges.

Over-the-counter hearing aids, approved in the United States in 2022 under a new FDA regulatory category, were designed to address this access barrier. By offering affordable, direct-to-consumer options, OTC devices enable more people to address mild-to-moderate hearing loss without expensive clinic visits. This approach is particularly valuable in regions with limited audiology infrastructure. Products like Panda Air, an affordable earbud-style hearing aid with16-channel WDRC, multi-band adaptive noise reduction, fast charging (60-hour case), and a 45-day return window, bring hearing support within reach of populations that might otherwise go without. This is how a specific treatment approach addresses a global disease burden problem identified by hearing research.

Expanding access to hearing treatment may not reverse Alzheimer's disease, but it can improve quality of life, reduce isolation, and preserve the social engagement that protects cognitive health. As this study suggests, the challenge of aging is managing overlapping burdens of multiple age-related conditions together. Hearing care is a critical piece of that puzzle.

Limitations of This Research

As a modeling study based on reported data from multiple countries with varying diagnostic infrastructure, this research is limited by the quality and completeness of underlying surveys. Wealthier nations may report higher disease prevalence simply because they diagnose more cases. This bias toward over-reporting in developed countries could explain some of the SDI associations observed.

The study also cannot determine causality. The positive relationship between ARHL and AD burden may reflect aging demographics, shared reporting practices, or other unmeasured factors. Projections to 2040 are based on trend continuation and do not account for potential breakthroughs in prevention or treatment.

What This Means for Planning Ahead

The global burden of age-related hearing loss and Alzheimer's disease is shifting. Public health planners, clinicians, and individuals facing age-related hearing loss should view these two conditions as part of a larger aging health landscape. Coordinated interventions addressing sensory and cognitive health together, along with expanded access to affordable hearing care, offer a path forward for aging populations everywhere.

Liu D, Zhang Y, Zhang S. Global, regional, and national burden of age-related hearing loss and Alzheimer's disease, 1990-2021, with projections to 2040. Archives of Gerontology and Geriatrics, February 13, 2026. Retrieved from PubMed. DOI: 10.1016/j.archger.2026.106170